Radiotherapy clinical trial enrollment during the COVID-19 pandemic

Authors

  • Brian De Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Kelsey W. Kaiser Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Ethan B. Ludmir Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Debra N. Yeboa Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Chad Tang Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Karen E. Hoffman Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Zhongxing Liao Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Albert C. Koong Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Benjamin D. Smith Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

DOI:

https://doi.org/10.1080/0284186X.2020.1865564

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2021-04-03

How to Cite

De, B., Kaiser, K. W., Ludmir, E. B., Yeboa, D. N., Tang, C., Hoffman, K. E., … Smith, B. D. (2021). Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncologica, 60(3), 312–315. https://doi.org/10.1080/0284186X.2020.1865564

Issue

Vol. 60 No. 3 (2021): Acta Oncologica

Section

Articles